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ABSTRACT	
Though	understanding	how	different	characteristics	of	the	patient	and	session	influence	outcomes	of	
genetic	counseling	(GC)	is	important,	little	research	data	currently	exits	on	this	topic.	We	conducted	a	
retrospective	review	of	charts	from	patients	who	attended	a	specialist	psychiatric	GC	clinic	between	
February	1,	2012	and	January	31,	2017.	We	extracted	data	to	explore	the	effects	of	patient	and	session-
related	variables	on	Genetic	Counseling	Outcome	Scale	scores	(GCOS,	validated	instrument	that	
measures	empowerment).	We	used	ANOVA	to	analyze	the	pre-,	to	one-month	post-GC	change	in	GCOS	
scores	in	relation	to	eleven	variables.	307	charts	were	included	in	analysis.	Overall,	GCOS	scores	
significantly	increased	after	GC	(p<0.0005).	No	significant	differences	in	GCOS	change	scores	were	
identified	with	respect	to:	sex,	ethnicity,	diagnosis,	mode	of	referral,	type	of	appointment,	genetic	
counseling	student	involvement,	presence	of	observers	or	personal/family	history	of	mental	illness.	
Significant	relationships	were	found	between	GCOS	change	scores	and	mode	of	delivery	of	GC	(p=0.048,	
h2	=	0.020)	and	primary	indication	for	the	appointment	(understanding	recurrence	risk	versus	other,	
p=0.001,	h2	=	0.037).	This	exploratory	study	provides	the	first	data	on	how	a	number	of	characteristics	
of	the	patient	and	session	influence	outcomes	of	genetic	counseling.	Understanding	the	patient	and	
session-related	factors	that	do	seem	to	influence	outcomes	may	allow	for	adjustment	of	service	delivery	
strategies	to	promote	the	best	possible	outcomes.	
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INTRODUCTION	
It	has	become	increasingly	important	for	the	genetic	counseling	profession	to	demonstrate	the	value	of	
genetic	counseling	through	research	evaluating	patient	outcomes.	The	National	Society	of	Genetic	
Counselors	(NSGC)	has	prioritized	the	identification	of	outcomes	unique	to	genetic	counseling,	for	use	
in	outcome	research	and	clinical	intervention	(Redlinger-Grosse	et	al.,	2016).	Since	outcomes	in	the	
field	of	genetic	counseling	have	yet	to	be	well	defined,	a	recent	study	aimed	to	elucidate	and	categorize	
outcomes	defined	by	diverse	groups	of	practicing	genetic	counselors	(Zierhut,	Shannon,	Cragun,	&	
Cohen,	2016).	The	most	common	outcome	themes	involved	appropriate	ordering	of	genetic	tests	and	
accurate	interpretation	of	results,	adherence	to	appropriate	medical	management,	psychosocial	
outcomes	and	patient	and	provider	knowledge	(Zierhut	et	al.,	2016).	An	additional	unique	outcome	
identified	was	the	impact	of	genetic	counseling	on	family	member	outcomes	(Zierhut	et	al.,	2016).	
	
Important	patient	related	outcomes	such	as	satisfaction,	knowledge	and	empowerment	have	been	
identified	and	validated	through	a	growing	body	of	studies.	The	majority	of	genetic	counseling	outcome	
studies	have	focused	on	cancer	genetic	counseling	(Burke	et	al.,	2000;	Cabrera,	Blanco,	Yagüe,	&	
Zabalegui,	2010;	Cragun	et	al.,	2015;	Oberguggenberger	et	al.,	2016).	These	studies	demonstrated	that	
after	genetic	counseling	patients	had	more	accurate	perceptions	of	cancer	risk,	they	were	more	
knowledgeable	about	cancer	and	were	less	anxious	about	their	personal	cancer	risk	(Burke	et	al.,	2000;	
Cabrera	et	al.,	2010).	Additional	research	to	date	indicates	that	genetic	counseling	increases	the	level	of	
patient	knowledge	and	positive	health	behaviors,	while	decreasing	anxiety	and	decisional	conflict	
(Madlensky	et	al.,	2017).	There	is	increasing	evidence	that	the	most	important	outcomes	of	genetic	
counseling	are	psychosocial,	which	is	in	accordance	to	a	psychotherapeutically	oriented	approach	in	
this	field,	and	demonstrates	the	validity	of	these	outcome	measures	(Austin,	Semaka,	&	Hadjipavlou,	
2015).	Empowerment	has	been	identified	as	a	patient	benefit	from	clinical	genetic	services,	and	can	be	
defined	as	a	set	of	beliefs	that	enable	an	individual	to	feel	that	they	have	some	control	over	and	hope	for	
the	future	(Marion	Mcallister,	Dunn,	&	Todd,	2011).	
	
	
In	addition	to	the	lack	of	research	evaluating	patient	outcomes,	limited	research	has	analyzed	the	
effects	of	patient	or	session-related	variables	on	genetic	counseling	outcomes.	Several	studies	have	
addressed	potential	differences	between	modes	of	genetic	counseling;	specifically	telephone	genetic	
counseling	versus	traditional	in-person	genetic	counseling.	A	randomized	non-inferiority	trial	
comparing	pre-	and	post-test	telephone	BRCA1/2	genetic	counseling	to	standard	in-person	genetic	
counseling	showed	no	significant	differences	between	knowledge,	satisfaction,	decision	conflict	and	
cancer	distress	two-weeks	and	three-months	post	genetic	counseling	(Schwartz	et	al.,	2014).	There	isn’t	
sufficient	evidence	to	support	the	telephone	genetic	counseling	model	as	a	comparative	alterative	to	in-
person	counseling	with	respect	to	all	patient	outcomes.	However,	research	does	indicate	many	positive	
and	comparable	outcomes.	A	recent	study	demonstrated	that	method	of	obtaining	family	history	
information	had	a	significant	impact	on	patient-reported	self-efficacy	(Slomp,	Morris,	Inglis,	Lehman,	&	
Austin,	2017).	Specifically,	there	was	a	significant	increase	in	IMSES	scores,	one-month	after	genetic	
counseling,	for	individuals	who	had	their	family	history	taken	before	their	appointment,	and	a	non-
significant	decrease	in	IMSES	scores,	one-month	post	genetic	counseling,	for	individuals	who	had	their	
family	history	taken	during	the	appointment	(Slomp	et	al.,	2017).	The	IMSES	is	an	instrument	that	
measures	confidence	in	managing	psychiatric	illness	(Slomp	et	al.,	2017).	
	
While	the	effects	of	referral	type	have	not	been	researched	in	the	context	of	a	genetic	counseling	
appointment,	some	preliminary	studies	suggest	a	difference	in	outcomes	between	individuals	who	self-
refer	and	those	who	are	referred	by	a	health	care	provider	in	clinical	genetics	and	healthcare	services	
(Christensen	et	al.,	2015;	Snyder	et	al.,	2008).	In	a	study	examining	the	behavioral	impact	of	genetic	risk	
information	for	Alzheimer’s	disease,	self-referred	participants	were	more	likely	than	actively	recruited	
participants	to	make	behavioral	changes,	such	as	changes	in	mental	activities	and	diet,	based	on	their	
genetic	risk	assessment	results	(Christensen	et	al.,	2015).	In	another	study,	cancer	survivors	who	self-
referred	to	a	study	testing	the	efficacy	of	diet	and	exercise	interventions	had	greater	increases	in	
	
weekly	exercise	minutes	and	fruit	and	vegetable	consumption	compared	to	those	who	were	referred,	
and	displayed	greater	motivation	to	respond	to	educational	materials	(Snyder	et	al.,	2008).	
Investigating	the	potential	differences	between	self-referrals	and	referrals	from	a	health	care	provider	
to	genetic	counseling	services,	and	their	relationship	with	outcome	measures,	may	provide	insight	into	
future	modes	of	referral	for	genetic	counselors.	
	
In	a	first-year	evaluation	of	a	specialized	psychiatric	genetic	counseling	clinic	in	Vancouver,	BC	there	
were	significant	increases	shown,	one-month	post	genetic	counseling,	in	the	baseline	levels	of	
empowerment	(p<0.0001)	and	self-efficacy	(p=0.011)	(Inglis,	Koehn,	Mcgillivray,	Stewart,	&	Austin,	
2015).	There	is	little	research	evaluating	the	impact	of	different	patient	and	session	variables	on	levels	
of	empowerment,	and	limited	research	on	other	outcomes.	While	some	research	has	evaluated	modes	
of	genetic	counseling	service	delivery	and	method	of	family	history	taking,	no	research	has	examined	
the	effects	of	other	variables	such	as	sex,	ethnicity,	diagnosis,	modes	of	referral,	primary	indication	for	
referral,	type	of	appointment,	genetic	counseling	student	involvement,	presence	of	observers,	special	
group	designation,	and	personal	and	family	histories	of	mental	illness	on	patient	outcomes	of	genetic	
counseling.	We	aim	to	perform	an	exploratory	story	that	examines	the	change	(from	before,	to	one-
month	post	genetic	counseling)	in	levels	of	empowerment	with	respect	to	several	variables.	
Understanding	factors	that	influence	outcome	measures	may	allow	for	adjustment	of	service	delivery	
strategies	to	promote	the	best	possible	outcomes	for	different	types	of	patients	attending	genetic	
counseling	sessions.	
	
MATERIALS	AND	METHODS	
Participants	and	Procedure	
We	conducted	a	retrospective	chart	review	using	data	from	patients	who	received	genetic	
counseling	at	a	specialist	psychiatric	genetic	counseling	clinic	in	Vancouver,	BC,	between	February	1,	
2012	and	January	31,	2017,	and	were	entered	into	a	clinical	database.	Typically,	all	English-speaking	
	
patients	who	attend	this	clinic	complete	the	Genetic	Counseling	Outcome	Scale	(GCOS)	prior	to	
genetic	counseling	(T1)	and	again	at	the	standard	one-month	follow-up	time	point	(T2).	This	clinical	
instrument	is	used	at	T1,	along	with	the	Illness	Management	Self	Efficacy	Scale	(ISMES)	for	patients	
with	a	personal	lived	experience	of	mental	illness,	to	assist	the	genetic	counselor	in	establishing	
pertinent	discussion	points	for	the	session.	At	T2,	these	clinical	instruments	aid	in	assessing	how	the	
patient	is	doing	and	what	additional	topics	may	need	to	be	addressed.	We	did	not	assess	ISMES	
scores	in	this	study.	For	a	further	description	on	the	psychiatric	genetic	counseling	clinic	see	Inglis	et	
al.,	2014.	The	following	patient	data,	stored	in	a	de-identified	clinical	database	includes,	but	is	not	
limited	to:	demographic	information,	diagnosis,	mode	of	referral	(self-referral	or	referral	from	a	
health	care	provider),	mode	of	genetic	counseling	(in-person,	telephone	or	telehealth),	primary	
indication	for	referral,	type	of	appointment	(family	or	individual),	genetic	counseling	student	
involvement	(yes	or	no),	presence	of	observers	(yes	or	no),	special	group	designation	(referrals	from	
BC	Children’s	Hospital	OCD	clinic,	referrals	for	inpatients	at	Burnaby	Centre	for	Mental	Health	and	
Addictions,	or	no	special	group	designation),	personal	and	family	histories	of	mental	illness	and	
GCOS	scores.	We	extracted	patient	data	that	met	the	following	criteria:	(1)	they	attended	their	first	
appointment	between	February	1,	2012	and	January	31,	2017,	(2)	the	patient	was	the	primary	
individual	attending	the	appointment,	and	(3)	the	patient	had	completed	the	GCOS	prior	to	(T1)	and	
one-month	post	(T2)	genetic	counseling.	The	primary	individual	attending	the	appointment	is	
defined	as	the	original	patient	referred,	and	not	a	family	member	or	additional	individual	attending	
the	appointment.	Institutional	Review	Board	approval	was	received	from	the	BC	Children	and	
Woman’s	Research	Ethics	Board	(H15-02632).		
	
Quantitative	Instrument	
The	GCOS	is	a	validated,	clinical	genetics-specific	PROM	(patient	reported	outcome	measure)	(M.	
Mcallister,	Wood,	Dunn,	Shiloh,	&	Todd,	2011).	This	instrument	measures	levels	of	empowerment,	
incorporating	components	such	as	perceived	personal	control,	emotional	regulation,	benefits	to	
	
other	relatives,	and	hope	for	the	future	(M.	Mcallister	et	al.,	2011).	All	24	items	are	rated	on	a	7-point	
Likert	scale	(1=	strongly	disagree,	7	=	strongly	agree).		Scores	range	from	24	to	168	with	higher	
scores	indicating	higher	levels	of	empowerment.	All	patients	attending	the	psychiatric	genetic	
counseling	clinic,	including	those	with	personal	and/or	family	histories	of	mental	illness,	completed	
the	GCOS	whenever	it	was	appropriate.	Instances	where	patients	would	not	complete	the	GCOS	at	
one	or	both	of	the	time	points	would	include	when:	(1)	the	patient	is	actively	experiencing	
symptoms	of	psychosis,	(2)	time	constraints	of	appointment,	or	(3)	the	patient	declines.	
	
Data	Analyses	
Descriptive	statistics	were	applied	to	the	demographic	data,	and	GCOS	total	scores	at	T1	and	T2	were	
calculated	according	to	instrument-specific	instructions.	In	accordance	to	these,	any	patients	who	
declined	to	answer	6	or	more	questions	on	the	instrument	were	removed	from	analysis.	We	
conducted	a	paired	sample	t	test	to	compare	the	overall	change	in	GCOS	scores	from	T1	to	T2.	We	
used	a	significance	threshold	of	p<0.05.	Next,	we	conducted	one-way	between-group	analyses	of	
variance	(ANOVAs)	for	each	variable	using	mean	GCOS	change	scores	(T2	–	T1),	and	a	significance	
threshold	of	p<0.05.	We	excluded	any	group	where	the	sample	size	was	equal	to	one,	due	to	
constraints	of	the	analysis	parameters.	For	the	special	groups	designation	variable,	there	were	5	
patients	categorized	as	22q11.2	referrals	who	were	excluded	since	they	will	be	assessed	in	another	
study.	For	this	variable,	we	conducted	separate	ANOVAs	comparing	referrals	from	BC	Children’s	
Hospital	OCD	clinic	to	patients	with	no	special	group	designation,	and	referrals	from	inpatients	at	
Burnaby	Centre	for	Mental	Health	and	Addictions	to	patients	with	no	special	group	designation.	For	
two	variables,	primary	indication	for	referral	and	personal	history	of	mental	illness,	patients	in	the	
clinical	database	were	present	in	more	than	one	group.	For	this	reason,	an	ANOVA	was	conducted	
separately	for	each	group	within	the	primary	indication	for	referral	variable.	A	composite	variable	
was	created	for	the	personal	history	of	mental	illness	variable,	and	we	conducted	an	ANOVA	for	
individuals	with	a	personal	history	of	schizophrenia,	bipolar	disorder	or	schizoaffective	disorder.	
	
Any	additional	diagnoses	were	described.		Assumptions	for	continuity,	independence	of	
observations,	and	normality	were	met.	The	homogeneity	of	variance	assumption	was	met	for	all	
variables	except	the	Burnaby	Centre	referrals	group	in	the	special	group	designation	variable.	For	
that	analysis,	we	used	a	Welch	test	instead	of	ANOVA,	and	a	significance	threshold	of	p<0.05.	For	
variables	with	a	significant	ANOVA	(p<0.05),	we	performed	the	Tukey’s	HSD	post	hoc	analysis,	with	
a	significance	threshold	of	p<0.05.	These	analyses	were	performed	using	IBM	SPSS	Statistics	24.		
	
RESULTS	
There	were	318	patients	in	the	clinical	database	that	met	the	inclusion	criteria.	Of	those,	307	had	no	
more	than	5	unanswered	items	in	the	GCOS	instrument	at	either	T1	or	T2	time	points.	The	average	
age	of	patients	analyzed	were	41	years	old,	the	majority	were	female	(83.4%),	and	the	most	common	
ethnicity	was	European	(67.8%).	Comprehensive	demographic	data	is	shown	in	Table	1.		
Table	1	Demographic	information	
	 All	patients	(included	in	analysis)	
N	=	307	
Age	[mean(sd)]	 41.13	(12.09)	
Sex	[n	(%)]	
Male	
Female	
Other	
	
50	(16.3)	
256	(83.4)	
1	(0.3)	
Ethnicity	[n	(%)]	
European	
Asian	
Aboriginal	
African	
Mixed	
Other	
Unknown	
	
208	(67.8)	
46	(15.0)	
1	(0.3)	
3	(1)	
34	(11.1)	
3	(1)	
12	(3.9)	
Personal	History	of	Mental	Illness	[n]1	
Schizophrenia	
Bipolar	disorder	
Schizoaffective	
OCD	
Depression	
Anxiety	
Eating	disorder	
ADD/ADHD	
Autism/ASD	
PTSD	
Borderline	Personality	disorder	
Addiction	
	
17	
55	
6	
12	
168	
118	
13	
11	
1	
21	
6	
28	
	
Other	
Family	History	Only	
19	
48	
1Patients	may	have	more	than	one	diagnosis	
Table	2	Assessment	of	GCOS	scores	using	paired	sample	t	tests		
	 All	patients	(included	in	analysis)	
N	=	307	
GCOS	T1	scores	[mean	(sd)]	 111.09	(17.68)	
GCOS	T2	scores	[mean	(sd)]	 127.17	(18.20)	
Change	(T2-T1)	[mean	(sd)]	 16.08	(14.63)	
p	value	 <0.0005	
Cohen’s	d	 1.10	
	
Overall,	GCOS	scores	significantly	increased	from	T1	to	T2	(p<0.0005,	d=1.10)	(see	Table	2).	There	
was	no	significant	difference	in	GCOS	change	scores	(T2	–	T1)	for	individuals	of	different	sex	(F	(1,	
304)	=	2.158,	p=0.143)	or	ethnicity	(F	(4,	289	=	0.727),	p=0.574).	There	were	no	significant	
differences	in	GCOS	change	scores	with	respect	to:	mode	of	referral	(F	(1,	305)	=	1.266,	p=0.261),	
types	of	appointment	(F	(1,	305)	=	0.326,	p=0.568),	genetic	counseling	student	involvement	(F	(1,	
299)	=	0.036,	p=0.851)	or	presence	of	observers	(F	(1,	167	=	0.061,	p=0.805).	Additionally,	there	
were	no	significant	differences	in	GCOS	change	scores	comparing	referrals	from	BC	Children’s	
hospital	OCD	clinic	patient	to	referrals	with	no	special	group	designation	(F	(1,	289)	=	0.099,	
p=0.754),	or	comparing	referrals	from	Burnaby	Centre	for	Mental	Health	and	Addictions	to	referrals	
with	no	special	group	designation	(Welch’s	F	(1,	10.328)	=	2.553,	p=0.140).	
	
A	significant	relationship	was	found	between	GCOS	change	scores	and	mode	of	genetic	counseling	(F	
(2,	304)	=	3.067,	p=0.048).	The	effect	size	was	small	(h2	=	0.020),	and	Tukey’s	post	hoc	analysis	
identified	no	significant	differences	between	groups.	There	was	a	quantitative	increase	in	GCOS	
change	scores	from	the	telephone	genetic	counseling	group	(M	=	12.49,	SD	=	13.35)	to	the	in-person	
counseling	group	(M	=	17.11,	SD	=	14.84),	a	mean	increase	of	4.62,	SE	=	2.29,	which	was	not	
statistically	significant	(p=0.111).	There	was	also	a	quantitative	increase	in	GCOS	change	scores	from	
the	telehealth	genetic	counseling	group	(M	=	10.80,	SD	=	12.90)	to	the	in-person	genetic	counseling	
	
group	(M	=	17.11,	SD	=	14.84),	a	mean	increase	of	6.31,	SE	=	3.87,	but	it	was	not	statistically	
significant	(p=0.234).	There	was	a	significant	increase	in	GCOS	change	scores	for	patients	who	stated	
that	recurrence	risk	was	a	primary	indication	for	referral,	compared	to	those	who	did	not	(F	(1,	305)	
=	11.624,	p=0.001).	The	effect	size	was	small	to	medium	(h2	=	0.037).	There	were	no	significant	
differences	in	GCOS	change	scores	for	patients	who	stated	other	primary	indications,	including:	
understanding	causes	of	mental	illness	(F	(1,	305)	=	1.149,	p=0.285),	information	regarding	
protective	factors	(F	(1,	305)	=	0.618,	p=0.411),	previous	genetic	testing	(1,	305)	=	0.005,	p=0.942),	
pregnancy	related	(F	(1,	305)	=	0.925,	p=0.337),	other	primary	indications	(F	(1,	305)	=	2.034,	
p=0.155,	or	unsure	about	primary	indication	(F	(1,	305)	=	3.368,	p=0.067),	compared	to	those	who	
didn’t.	There	were	no	significant	differences	in	GCOS	change	scores	comparing	individuals	with	a	
personal	history	of	mental	illness,	to	those	with	a	family	history	only	(F	(1,	305)	=	1.233,	p=0.268).	
Finally,	there	was	no	significant	difference	in	GCOS	change	scores	between	individuals	with	a	
diagnosis	of	schizophrenia,	bipolar	disorder	or	schizoaffective	disorder	(F	(2,	77)	=	2.422,	p=0.096).	
Table	3	Comparison	of	GCOS	change	scores	using	a	one-way	between	groups	ANOVA	
	 	
n	
	
T1	mean	(sd)	
	
T2	mean	(sd)	
Change	(sd)	
(T2-T1)	
ANOVA	
p	value	
	
h2	
Sex	
Male	
Female	
Other	
	
50	
256	
1	
	
111.65	(17.15)	
110.93	(17.82)	
124.00	
	
125.05	(19.50)	
127.63	(17.97)	
114.78	
	
13.40	(17.26)	
16.70	(13.97)	
-9.22	
	
0.1432	
	
0.007	
Ethnicity	
European	
Asian	
Aboriginal	
African	
Mixed	
Other	
	
208	
46	
1	
3	
34	
3	
	
111.38	(17.42)	
113.48	(15.73)		
111.00	
95.29	(17.28)	
107.22	(22.22)	
108.57	(25.75)	
	
128.30	(17.69)	
126.93	(17.83)	
110.00	
111.29	(29.65)	
124.46	(17.18)	
118.49	(43.85)	
	
16.92	(14.60)	
13.45	(14.05)	
-1.00	
16.00	(12.62)	
17.23	(13.56)	
9.93	(19.13)	
	
0.5742	
	
0.010	
Mode	of	referral	
Self-referral	
Health	care	provider	
	
114	
193	
	
109.62	(16.38)	
111.96	(18.38)	
	
124.48	(18.12)	
128.76	(18.11)	
	
14.86	(15.61)	
16.80	(14.01)	
	
0.261	
	
0.004	
Mode	of	GC	
Telephone	
In-person	
Telehealth	
	
48	
244	
15	
	
111.08	(19.54)	
110.89	(17.22)	
114.37	(19.64)	
	
123.57	(18.47)	
128.00	(18.13)	
125.17	(18.15)	
	
12.49	(13.35)	
17.11	(14.84)	
10.80	(12.90)	
	
0.048	
	
0.020	
Primary	Indication	
Recurrence	risk	
Understanding	causes	
Protective	factors	
Had	genetic	testing	
	
147	
189	
81	
4	
	
110.87	(17.56)	
110.47	(17.80)	
114.76	(16.98)	
93.39	(18.03)	
	
129.87	(16.04)	
127.26	(18.58)	
129.69	(18.11)	
110.00	(23.76)	
	
19.00	(13.83)	
16.79	(14.72)	
14.93	(12.52)	
16.61	(17.17)	
	
0.001	
0.285	
0.411	
0.942	
	
0.037	
0.004	
0.002	
0.000	
	
Pregnancy	related	
Other	
Unsure	
17	
6	
20	
121.74	(15.41)	
98.00	(10.55)	
117.19	(13.98)	
134.50	(15.50)	
122.50	(13.03)	
127.49	(21.56)	
12.76	(9.37)	
24.50	(10.03)	
10.30	(17.84)	
0.337	
0.155	
0.067	
0.003	
0.007	
0.011	
Type	of	appointment	
Family	
Individual	
	
89	
218	
	
110.72	(16.16)	
111.24	(18.29)	
	
127.54	(16.63)	
127.02	(18.84)	
	
16.83	(15.60)	
15.78	(14.24)	
	
0.568	
	
0.001	
GC	student	involvement	
Yes	
No	
	
72	
229	
	
112.45	(17.23)	
110.59	(17.70)	
	
128.51	(20.62)	
127.03	(17.23)	
	
16.06	(13.45)	
16.44	(14.99)	
	
0.851	
	
0.000	
Presence	of	observer	
Yes		
No	
	
38	
131	
	
116.31	(15.20)	
111.51	(17.92)	
	
132.45	(17.18)	
127.04	(18.11)	
	
16.13	(11.82)	
15.53	(13.75)	
	
0.805	
	
0.000	
Special	Groups	
OCD	clinic	
Burnaby	Centre	
None	
	
16	
11	
275	
	
118.22	(19.93)	
116.68	(16.82)	
110.20	(17.48)	
	
133.63	(16.95)	
122.25	(25.45)	
126.76	(18.00)	
	
15.41	(9.92)	
5.57	(22.62)	
16.56	(14.44)	
	
0.754	
0.1403	
	
0.000	
-	
History	of	Mental	Illness	
Personal	History		
Family	History	Only	
	
Personal	History	
Schizophrenia1	
Bipolar	disorder1	
Schizoaffective1	
	
259	
48	
	
	
17	
55	
6	
	
111.16	(18.10)	
110.73	(18.10)	
	
	
114.65	(16.78)	
112.03	(20.38)	
118.49	(14.61)	
	
127.64	(18.35)	
124.66	(18.35)	
	
	
123.85	(21.82)	
129.04	(18.19)	
123.17	(30.94)	
	
16.48	(14.61)	
13.93	(14.72)	
	
	
9.20	(18.15)	
17.01	(16.00)	
4.68	(23.18)	
	
0.268	
	
	
	
0.096	
	
	
	
0.004	
	
	
	
0.061	
1Includes	all	individuals	regardless	of	an	additional	diagnosis	
2Excluded	groups	where	n=1	for	the	purposes	of	this	analysis	
3Welch	analysis	performed	(homogeneity	of	variance	assumption	not	met)	
	
DISCUSSION	
In	order	to	assess	the	effectiveness	of	genetic	counseling	it	is	important	to	identify	and	measure	specific	
outcomes.	While	there	is	prior	research	focusing	on	these	two	goals,	and	limited	research	assessing	the	
effect	of	variables	on	outcomes,	this	is	the	first	study	to	examine	the	influence	of	multiple	patient	and	
session-related	variables	on	outcomes	in	genetic	counseling.	Overall,	there	was	a	significant	increase	in	
empowerment	following	genetic	counseling	(p<0.0005).	This	result	was	expected	based	on	previous	
research	(Inglis	et	al.,	2015;	Slomp	et	al.,	2017).	The	patient	variables	sex	and	ethnicity	had	no	impact	
on	levels	of	empowerment.	This	finding	demonstrates	that	patients	with	different	sexes	and	ethnicities	
benefit	from	psychiatric	genetic	counseling.	While	the	patient	variable	sex	captures	sex	assigned	at	
birth,	we	didn’t	assess	the	gender	identity	of	each	patient	which	would	capture	an	assessment	of	gender	
experience	and	outcomes	in	genetic	counseling.	There	was	one	patient,	who	met	inclusion	criteria,	who	
	
identified	as	transgender	however	we	had	to	exclude	them	when	performing	the	ANOVA	due	to	
constraints	of	the	analysis	parameters.	
	
Four	additional	variables	assessed	had	no	impact	on	levels	of	empowerment:	mode	of	referral	(self-
referral	or	referral	from	a	health	care	provider),	type	of	appointment	(individual	or	family),	genetic	
counseling	student	involvement	(yes	or	no)	and	presence	of	observers	(yes	or	no).	It’s	possible	that	
smaller	differences	in	levels	of	empowerment	between	these	groups	were	masked	by	large	increases	in	
levels	of	empowerment	for	all	patients.	While	the	GCOS	change	scores	were	quantitatively	larger	for	
those	who	were	referred	by	health	care	provider,	it	was	not	statistically	significant.	This	quantitative	
difference	could	be	explained	by	the	hypothesis	that	individuals	who	self-refer	have	higher	baseline	
levels	of	empowerment,	however	the	T1	GCOS	scores	were	not	significantly	different	between	the	two	
groups	(t	(305)	=	-1.119,	p=0.264).	Individuals	who	self-refer	may	have	stronger	personal	or	family	
histories	of	disease,	higher	levels	of	anxiety,	or	other	psychosocial	variables	that	may	play	a	role	in	their	
response	to	treatment	(Audrain	et	al.,	1998;	Henrikson,	Harris,	&	Bowen,	2007).	In	order	to	better	
elucidate	these	contributing	factors,	it	would	be	important	to	further	evaluate	these	two	groups	
regarding	their	main	concerns	and	personal	or	family	histories	of	mental	illness.	The	mode	of	referral	
may	have	no	impact	on	genetic	counseling	outcomes,	however	these	results	raise	the	importance	of	
educating	health	care	providers	about	the	benefits	and	outcomes	of	psychiatric	genetic	counseling.	The	
referring	health	care	providers	involved	in	this	study	included	psychiatrists,	general	practitioners,	
genetic	counselors	and	mental	health	workers.	Patients	experienced	increased	levels	of	empowerment,	
regardless	of	additional	individuals	attending	the	appointment,	including	other	family	members,	
genetic	counseling	students	who	participate	in	the	session	and	observers	who	don’t	participate.	In	fact,	
the	effect	sizes	are	remarkably	low	(h2	<	0.001).	This	demonstrates	that	the	effects	of	genetic	
counseling,	for	primary	patients,	are	not	affected	by	additional	attendees	such	as	their	children,	parents,	
or	spouses.	It	was	not	expected	that	the	presence	of	genetic	counseling	students	or	silent	observers	
would	impact	the	effects	of	psychiatric	genetic	counseling.		No	significantly	different	effect	of	genetic	
	
counseling	with	respect	to	special	group	designation	was	detected.	Importantly,	patients	referred	from	
the	Burnaby	Centre	had	quantitatively	lower	GCOS	change	scores	(M	=	5.57,	SD	=	22.62)	compared	to	
patients	who	weren’t	referred	from	a	special	group	(M	=	16.56,	SD	=	14.44),	however	the	differing	
sample	sizes	in	these	two	groups	and	non-homogeneity	of	variance	did	not	allow	for	elucidation	of	this	
finding.	This	warrants	further	investigation.	
	
The	mode	of	genetic	counseling	did	have	a	significant	impact	on	the	patient-reported	measure	of	
empowerment	(p=0.048).	While	Tukey’s	post	hoc	analysis	was	not	significant,	patients	who	received	in-
person	genetic	counseling	had	quantitatively	larger	GCOS	change	scores	compared	to	patients	who	
received	genetic	counseling	over	the	phone,	or	through	videoconference.	Only	48	patients	received	
telephone	genetic	counseling,	and	15	patients	were	seen	through	telehealth,	compared	to	244	patients	
who	came	in-person	to	their	genetic	counseling	appointment.	The	trend	demonstrated	is	larger	
increases	in	empowerment,	after	genetic	counseling,	for	individuals	who	receive	in-person	genetic	
counseling,	and	equivalent	samples	sizes	would	lend	support	to	this	observation.	A	randomized	trial	
comparing	telegenetics	to	in-person	cancer	genetic	counseling	reported	patient	satisfaction	did	not	
differ	by	group	on	either	satisfaction	scale,	but	also	identified	the	need	for	further	randomized	trials	to	
compare	longer-term	psychosocial	and	behavioral	outcomes	(Buchanan	et	al.,	2015).	Telephone	genetic	
counseling	has	the	potential	to	increase	access	to	comprehensive	genetic	services	and	decrease	costs,	
however	the	concerns	arise	when	considering	the	ability	to	translate	knowledge	and	provide	adequate	
patient	support	(Schwartz	et	al.,	2014).	It’s	important	to	assess	alternative	delivery	modes,	and	their	
relationship	with	patient	outcomes,	given	the	increased	demand	for	genetic	counseling	and	genetic	
testing.	Although	previous	literature	has	demonstrated	comparable	outcome	between	in-person	genetic	
counseling	and	telephone	genetic	counseling,	these	results	suggest	that	patients	benefit	from	in-person	
genetic	counseling,	with	respect	to	levels	of	empowerment.	
	
	
Primary	indications	for	referral	impacted	genetic	counseling	outcomes,	although	these	results	are	
interpreted	with	caution.	There	was	a	significant	increase	in	levels	of	empowerment	for	patients	who	
stated	that	understanding	recurrence	risk	was	a	primary	indication	for	referral,	compared	to	patients	
who	did	not	(p=0.001).	The	effect	size	was	small	to	medium	(h2	=	0.037),	indicating	that	increases	in	
levels	of	empowerment	can	be	moderately	attributed	to	that	primary	indication.	The	effects	of	genetic	
counseling	may	be	greater	when	patients	are	interested	in	understanding	the	recurrence	risk	estimates,	
related	to	mental	health	conditions,	for	themselves	or	their	family	members.	However,	some	patients	
within	the	understanding	recurrence	risk	group	stated	additional	primary	indications	for	referral	that	
could	be	confounding	these	results.	Our	approach	to	this	analysis	is	an	appropriate	first	step,	but	more	
in-depth	investigation	will	better	elucidate	how	patients	with	different	primary	concerns	benefit	from	
genetic	counseling.	No	effect	on	levels	of	empowerment	were	found	when	assessing	the	other	primary	
indications	individually,	including:	understanding	the	causes	of	mental	illness,	information	regarding	
protective	factors,	the	presence	of	previous	genetic	testing,	pregnancy	related	factors,	other	indications	
and	patients	who	were	unsure	of	their	primary	indication.		
	
History	of	mental	illness	had	no	impact	on	levels	of	empowerment	when	comparing	individuals	with	a	
personal	history	of	mental	illness	to	individuals	with	a	family	history	of	mental	illness	only.	
Additionally,	there	were	no	significant	differences	in	levels	of	empowerment	when	comparing	
individuals	with	a	personal	history	of	schizophrenia,	bipolar	disorder	or	schizoaffective	disorder.	
Previous	research	has	demonstrated	that	genetic	counseling	improves	knowledge	and	risk	perception	
accuracy	for	individuals	with	these	serious	mental	illnesses	(Hippman	et	al.,	2016).	Therefore,	we	chose	
to	expand	on	this	and	assess	the	impact	of	these	specific	diagnoses	on	levels	of	empowerment	after	
genetic	counseling.	Our	results	demonstrate	that	individuals	with	different	diagnoses	of	a	serious	
mental	illness	benefit	from	genetic	counseling.	Individuals	were	included	in	this	analysis	regardless	of	
additional	diagnoses	(anxiety,	depression	or	others).	
	
	
Study	limitations	
This	exploratory	study	was	conducted	using	a	convenience	sample,	and	therefore	there	was	no	
control	group.	All	client	data	was	accessed	retrospectively,	and	all	patients	included	received	genetic	
counseling.	Additional	limitations	include	the	patient	demographics.	The	majority	of	patients	were	
female,	European	and	had	a	personal	history	of	mental	illness	(Personal	history	n	=	259,	Family	
history	only	n	=	48).	The	psychiatric	diagnoses	were	per	patient	report,	and	not	confirmed.	
Furthermore,	GCOS	scores	were	measured	one-month	after	genetic	counseling,	but	longer-term	
effects	were	not	assessed.	While	this	study	was	conducted	in	a	specialist	clinic,	we	predict	that	these	
results	translate	to	all	areas	of	the	genetic	counseling	profession	although	validation	is	warranted.	
	
Practice	implications	
These	findings	highlight	the	importance	of	educating	genetic	counselors	about	specific	patient	
outcomes,	and	indicates	a	need	to	delineate	the	influence	that	patient	and	session-related	variables	
have	on	outcomes	in	genetic	counseling.	Evaluating	outcomes	in	clinical	genetics	has	been	difficult	
because	traditional	measures	of	health	status	are	not	applicable	in	chronic	genetic	conditions	(M.	
Mcallister	et	al.,	2011).	This	study	utilizes	the	validated	GCOS-24,	that	captures	the	construct	of	
empowerment	as	an	outcome	of	genetic	counseling.	GCOS-24	includes	aspects	of	perceived	personal	
control,	which	is	considered	a	valid	outcome	measure	for	genetic	counseling	and	extends	beyond	
traditionally	accepted	educational	outcomes	(Berkenstadt,	Shiloh,	Barkai,	Katznelson,	&	Goldman,	
1999).		It	also	captures	emotional	regulation	and	hope	for	the	future,	which	has	not	been	included	in	
previous	questionnaires	(M.	Mcallister	et	al.,	2011).	Our	data	demonstrates	that	patients	with	
different	ethnicities,	sexes	and	diagnoses	benefit	from	psychiatric	genetic	counseling,	and	that	
patient	and	session-related	variables	do	seem	to	influence	genetic	counseling	outcomes.	As	an	
exploratory	study	these	findings	provide	an	initial	framework	for	future	studies	to	expand	on,	and	
highlight	the	implications	that	evidence	based	research	may	have	on	genetic	counseling	practice.	
	
	
Research	recommendations	
This	research	lends	support	to	future	areas	of	research,	including	other	factors	that	may	influence	
patient	outcomes	such	as	coping	style.	In	studies	analyzing	the	effect	of	coping	style	on	emotional	
outcomes	after	testing	and	cancer	genetic	counseling,	researchers	found	that	individuals	with	a	“high	
monitoring”	coping	style	have	a	greater	desire	for	information	regarding	their	illness	and	may	have	a	
higher	need	for	certainty	with	respect	to	test	results	(Nordin,	K.,	Liden,	A.,	Hansson,	M.,	Rosenquist,	R.,	
Berglund,	2002;	Shiloh,	S.,	Koehly,	L.,	Jenkins,	J.,	Martin,	J.,	Hadley,	2008).	One	common	genetic	
counseling	outcome	theme	identified	by	Zierhut	et	al.,	2016	was	adherence	to	medical	management,	
which	could	be	explored	in	future	research	assessing	adherence	to	medication,	or	the	number	of	
presentations	to	clinics	or	hospitals.	It	is	important	to	acknowledge	that	themes	involving	genetic	
testing	and	adherence	to	appropriate	medical	management	are	not	common	in	genetic	counseling	
outcome	literature,	while	psychosocial	outcomes	and	levels	of	knowledge	are	very	commonly	
discussed.	This	could	represent	changes	in	the	field,	such	as	an	increasing	number	of	variants	of	
uncertain	significance	(VUS),	as	we	are	implementing	testing	ahead	of	our	ability	to	explain	all	genetic	
variation.	Additionally,	there	are	limited	studies	looking	at	long-term	health	outcomes,	and	the	diverse	
practice	settings	in	which	genetic	counselors	work	(Madlensky	et	al.,	2017).	An	additional	outcome,	that	
we	were	unable	to	assess	in	this	study,	was	the	impact	of	genetic	counseling	on	family	members.	Future	
research	could	assess	levels	of	empowerment	for	family	members	of	primary	patients,	as	measured	by	
the	GCOS.	Furthermore,	we	did	not	assess	family	history	of	mental	illness	with	respect	to	different	
diagnoses.	Finally,	the	primary	indications	for	referral	variable	can	be	divided	further	to	compare	
whether	this	concern	is	related	to	the	patient	themselves,	or	to	others.		
	
CONCLUSION	
	
This	exploratory	study	provides	the	first	data	on	how	a	number	of	characteristics	of	the	patient	and	
session	influence	outcomes	of	genetic	counseling.	Patients	benefit	from	psychiatric	genetic	counseling,	
regardless	of	sex,	ethnicity,	diagnosis,	history	of	mental	illness,	students,	observers	and	additional	
	
attendees.	We	demonstrate	that	in-person	genetic	counseling	may	lead	to	greater	outcomes	for	
patients,	and	that	variables	such	as	the	primary	indications	for	referral,	specifically	understanding	
recurrence	risk,	may	predict	different	outcomes	of	genetic	counseling	for	patients.	Furthermore,	it	adds	
continued	support	to	the	value	in	psychiatric	genetic	counseling	for	individuals	with	a	personal	or	
family	history	of	mental	illness.	There	is	a	need	for	more	evidence	based	research	evaluating	patient	
outcomes	in	genetic	counseling,	which	is	useful	in	order	to	better	understand	how	current	services	
meet	patient’s	needs,	and	which	changes	in	service	delivery	will	be	the	most	effective.	
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